Indication

Reduction of allogeneic blood transfusion in surgery

Reduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management. Read more about Reduction of allogeneic blood transfusion in surgery

5 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Reduction of allogeneic blood transfusion in surgery therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Reduction of allogeneic blood transfusion in surgery preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Reduction of allogeneic blood transfusion in surgery.

Reduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management.

It addresses the hematologic complication of acute perioperative blood loss and surgical anemia in patients undergoing major elective or emergency procedures.

Severe blood loss compromises oxygen-carrying capacity and hemodynamic stability, historically necessitating donor red blood cell administration.

Limiting exposure to allogeneic blood aims to mitigate transfusion-associated risks, including transfusion-related acute lung injury, hemolytic or febrile reactions, immunomodulation, surgical site infections, and transmission of bloodborne pathogens.

Personalize your experience

Follow Reduction of allogeneic blood transfusion in surgery and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it